Tepmetko: payments to doctors
Payments that named Tepmetko as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $881K
- Providers
- 1,180
- Transactions
- 2,055
- Average per transaction
- $429
The per-transaction average — $429 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,180 providers the average total is $747, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| EMD Serono, Inc. | $862,792 | 97.9% |
| Merck Kgaa | $18,368 | 2.1% |